|Day Low/High||7.67 / 8.05|
|52 Wk Low/High||7.81 / 25.96|
Studying the indicators shows we’re overbought and still complacent, but still some charts deserve special focus, like insider selling, the McClellan Summation Index and small caps.
Teva Pharmaceuticals USA, Inc. today announced that the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Company will present 31 scientific abstracts for AJOVY ® (fremanezumab-vfrm) injection at the 61 st Annual Scientific Meeting of the American Headache Society, taking place in...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its second quarter 2019 financial results on Wednesday, August 7, 2019 at 7:00 a.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today is proud to present the FOCUS exploratory endpoints results at the 5 th Congress of the European Academy of Neurology (EAN), Oslo, Norway from June 29 th - July 2 nd, 2019.
NEW ORLEANS, June 26, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.
PFE was ready to pay $160 billion until U.S. regulators blocked the deal.
The intermediate-term sentiment indicators don’t show too much giddiness -- yet -- but look at all the market has on its plate this week.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Tracleer ®1 (bosentan) tablets, 62.
Jim Cramer weighs in on U.S. Steel, Insperity, NovoCure, Aqua America, Universal Display, Teva Pharmaceuticals, Marathon Petroleum and more.
Jim Cramer says investing can be fun and rewarding -- if you really understand what you own. But keep your eye on the Fed this week.
Eli Lilly's plan to eliminate pain could have farther reaching positive effects than just migraines.
Shares of drugmaker Teva surge after receiving an upgrade from Oppenheimer, albeit with a reduced 12-month price target.
Be careful backing Buffett right now, his biggest holdings show increasing profit pressure.
When traders are flailing and investors are drowning, examples work best to illustrate what happens before a bottom is reached.
Shares of Warren Buffett's investment vehicle, Berkshire Hathaway, ended the day below $300,000 for the first time since late March.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that data from the Phase IIIb FOCUS study, which evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients who previously...
Shares of Teva plummet Tuesday after UBS downgrades the stock to neutral from buy in light of opioid-related litigation.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa ®1 (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.
U.S. stock futures are lower as caution still prevails amid concerns over the fate of trade talks between Washington and Beijing; the French government says it jobs protected needs in order to support the proposed merger of Fiat Chrysler and Renault; Alibaba is considering raising $20 billion through a second listing in Hong Kong, a report says.
Israeli drugmaker says its payment of $85 million to the state is not an admission of wrongdoing; Johnson & Johnson subsidiary Janssen Pharmaceuticals meanwhile also defends company and says its open to a resolution.
Teva Pharmaceuticals USA and related affiliates of Teva Pharmaceutical Industries Ltd.
Gainers trail losers in Warren Buffett's Berkshire portfolio.
NEW YORK, May 13, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Teva Pharmaceuticals Industries Limited ("Teva" or the "Company") (NYSE:TEVA).
China's retaliatory tariffs spark biggest selloff on Wall Street since January.
Do not try to pick a bottom on this stock.
Attorneys general from 44 states allege the nation's largest generic drugmakers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.